Percutaneous Nephrolithotomy Safety, Efficacy, and Outcomes: A 10-Year Experience of a Tertiary Care Center in South Lebanon

经皮肾镜取石术的安全性、有效性和疗效:黎巴嫩南部一家三级医疗中心10年的经验

阅读:1

Abstract

Percutaneous nephrolithotomy (PCNL) is the gold standard for treating large and complex renal stones. This study presents a comprehensive analysis of 221 PCNL procedures performed over a decade (2014-2024) at a tertiary healthcare center in South Lebanon, focusing on safety, efficacy, and factors influencing outcomes. Patients aged 15-80 years were included, with variables such as stone characteristics, operative details, and postoperative outcomes analyzed. The mean patient age was 50 ± 16 years. The mean stone size was 3.1 ± 1.1 cm, with single stones most common (n = 82, 37.1%). The mean operative time was 2.1 ± 0.9 hours, and the average postoperative hospital stay was 2.7 ± 1.2 days. Complication rates were low (3.6%), with only one grade IV complication reported. The stone-free rate one month postoperatively was 82.35% (n = 182), with a mean residual stone size of 0.81 ± 0.32 cm, and only 8.1% (n = 18) of patients required second interventions. Regression analysis highlighted the significant influence of surgical team experience on reducing operative time, while larger stone sizes were associated with longer procedures. Compared to international benchmarks, the study demonstrated shorter operative times, lower complication rates, and comparable stone-free outcomes, emphasizing the role of expertise, advanced technologies, and structured preoperative protocols. These findings underscore the safety and efficacy of PCNL in the studied population. The study calls for the establishment of universal benchmarks for PCNL safety and efficacy, alongside multicenter studies, to optimize clinical practices and standardize outcomes for better patient care globally.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。